LifeStance Health Group, Inc.
LFST
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.39% | 74.41% | -10.33% | 53.08% | 26.99% |
| Total Depreciation and Amortization | -2.94% | -18.74% | -17.57% | 1.56% | 13.23% |
| Total Amortization of Deferred Charges | -4.29% | 0.00% | -0.94% | -16.70% | -1.36% |
| Total Other Non-Cash Items | 20.79% | -25.96% | 22.78% | 151.68% | -65.00% |
| Change in Net Operating Assets | 287.08% | -191.33% | 126.35% | -286.68% | 274.69% |
| Cash from Operations | 174.25% | -48.43% | 301.76% | -230.03% | 166.24% |
| Capital Expenditure | -24.75% | 1.15% | -0.12% | 55.28% | -16.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.75% | 1.15% | -0.12% | 55.28% | -16.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39,202.33% | 0.14% | -0.14% | -12.63% | -0.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -253.01% | -84.86% | 58.82% | -34.28% | -5.41% |
| Cash from Financing | -100.44% | -41.41% | 41.09% | -107.88% | 1,767.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 232.07% | -58.30% | 227.73% | -181.10% | 197.89% |
